Page last updated: 2024-10-21

hydroxyindoleacetic acid and Syndrome

hydroxyindoleacetic acid has been researched along with Syndrome in 42 studies

(5-hydroxyindol-3-yl)acetic acid : A member of the class of indole-3-acetic acids that is indole-3-acetic acid substituted by a hydroxy group at C-5.

Syndrome: A characteristic symptom complex.

Research Excerpts

ExcerptRelevanceReference
"To study the purported role of central monoamine disturbances in the pathophysiology of the opsoclonus-myoclonus syndrome, the serotonin metabolite 5-hydroxyindoleacetic acid and the dopamine metabolite homovanillic acid were measured in cerebrospinal fluid samples from 27 affected children and 47 age- and gender-matched control subjects by high-pressure liquid chromatography with electrochemical detection."9.08Cerebrospinal fluid 5-hydroxyindoleacetic acid and homovanillic acid in the pediatric opsoclonus-myoclonus syndrome. ( Banasiak, K; Gospe, SM; Huang, Y; Noetzel, MJ; Pranzatelli, MR; Stanley, M; Tate, E, 1995)
"Combination treatment with fluoxetine and moclobemide did not provide any indication of development of the "serotonin syndrome."9.08Pharmacokinetic and pharmacodynamic interactions between fluoxetine and moclobemide in the investigation of development of the "serotonin syndrome". ( Amrein, R; Dingemanse, J; Gieschke, R; Guentert, T; Wallnöfer, A, 1998)
"The aim of the present study was to investigate the discriminative power of a series of variables (including determination of depressive symptomatology by means of a visual analogue scale, determination of personality traits by means of the Karolinska Scales of Personality, determination of monoamine metabolites in CSF, platelet MAO activities, serum cortisol before and after dexamethasone suppression and urinary melatonin) in differentiating chronic pain patients from healthy subjects, and patients with idiopathic pain syndromes from patients with neurogenic pain syndromes."7.67Discrimination of idiopathic pain syndromes from neurogenic pain syndromes and healthy volunteers by means of clinical rating, personality traits, monoamine metabolites in CSF, serum cortisol, platelet MAO and urinary melatonin. ( Almay, BG; Häggendal, J; Johansson, F; Oreland, L; von Knorring, L; Wetterberg, L, 1986)
"Exposure to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) produces a syndrome that resembles Parkinson's disease."7.67The clinical syndrome of striatal dopamine deficiency. Parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). ( Burns, RS; Ebert, MH; Kopin, IJ; LeWitt, PA; Pakkenberg, H, 1985)
"Treatment with 5-hydroxytryptophan (4-6 mg/kg) and carbidopa (0."6.70A novel neurodevelopmental syndrome responsive to 5-hydroxytryptophan and carbidopa. ( Abeling, N; Bergmann, C; Blau, N; Häring, M; Häusler, M; Heimann, G; Ramaekers, VT; Senderek, J; Zerres, K, 2001)
"To study the purported role of central monoamine disturbances in the pathophysiology of the opsoclonus-myoclonus syndrome, the serotonin metabolite 5-hydroxyindoleacetic acid and the dopamine metabolite homovanillic acid were measured in cerebrospinal fluid samples from 27 affected children and 47 age- and gender-matched control subjects by high-pressure liquid chromatography with electrochemical detection."5.08Cerebrospinal fluid 5-hydroxyindoleacetic acid and homovanillic acid in the pediatric opsoclonus-myoclonus syndrome. ( Banasiak, K; Gospe, SM; Huang, Y; Noetzel, MJ; Pranzatelli, MR; Stanley, M; Tate, E, 1995)
"Combination treatment with fluoxetine and moclobemide did not provide any indication of development of the "serotonin syndrome."5.08Pharmacokinetic and pharmacodynamic interactions between fluoxetine and moclobemide in the investigation of development of the "serotonin syndrome". ( Amrein, R; Dingemanse, J; Gieschke, R; Guentert, T; Wallnöfer, A, 1998)
" The interaction between tianeptine and drugs known to interfere with the uptake or release of serotonin (sertraline, buspirone, D-norfenfluramine) was then studied and, to ascertain the in vivo pharmacological relevance of tianeptine's effects, its ability to reduce the serotoninergic syndrome was evaluated."3.68In vivo studies on the enhancement of serotonin reuptake by tianeptine. ( Clavenna, A; De Luigi, A; De Simoni, MG; Manfridi, A, 1992)
"The aim of the present study was to investigate the discriminative power of a series of variables (including determination of depressive symptomatology by means of a visual analogue scale, determination of personality traits by means of the Karolinska Scales of Personality, determination of monoamine metabolites in CSF, platelet MAO activities, serum cortisol before and after dexamethasone suppression and urinary melatonin) in differentiating chronic pain patients from healthy subjects, and patients with idiopathic pain syndromes from patients with neurogenic pain syndromes."3.67Discrimination of idiopathic pain syndromes from neurogenic pain syndromes and healthy volunteers by means of clinical rating, personality traits, monoamine metabolites in CSF, serum cortisol, platelet MAO and urinary melatonin. ( Almay, BG; Häggendal, J; Johansson, F; Oreland, L; von Knorring, L; Wetterberg, L, 1986)
"Exposure to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) produces a syndrome that resembles Parkinson's disease."3.67The clinical syndrome of striatal dopamine deficiency. Parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). ( Burns, RS; Ebert, MH; Kopin, IJ; LeWitt, PA; Pakkenberg, H, 1985)
"26 patients with a paranoid-hallucinatory syndrome were treated with a fixed daily dose of haloperidol."3.65Clinical and biochemical parameters during neuroleptic treatment. I. Investigations with haloperidol. ( Ackenheil, M; Eben, E; Hippius, H; Rüther, E; Schilkrut, R, 1976)
"Treatment with 5-hydroxytryptophan (4-6 mg/kg) and carbidopa (0."2.70A novel neurodevelopmental syndrome responsive to 5-hydroxytryptophan and carbidopa. ( Abeling, N; Bergmann, C; Blau, N; Häring, M; Häusler, M; Heimann, G; Ramaekers, VT; Senderek, J; Zerres, K, 2001)
"Patients with carcinoid tumours require a multidisciplinary approach to their care."2.41Carcinoid syndrome symposium on treatment modalities for gastrointestinal carcinoid tumours: symposium summary. ( DiFrancesco, LM; Kinnear, S; McEwan, A; McKinnon, JG; Numerow, L; Pasieka, JL; Paterson, A; Rorstad, O; Skogseid, B; Yelle, CA, 2001)
"This syndrome is an anxiety state occurring in the presence of elevated levels of atmospheric or ambient cations and is associated with elevated central and peripheral serotonin levels."2.37The serotonin irritation syndrome--a new clinical entity? ( Giannini, AJ; Malone, DA; Piotrowski, TA, 1986)
" Dose-response curves created with 8-OH DPAT for the serotonin behavioral syndrome were similar in bile duct-resected and sham-operated rats."1.33Fatigue of cholestasis and the serotoninergic neurotransmitter system in the rat. ( Bozdayi, AM; Bozkaya, H; Celik, T; Cinar, K; Gören, MZ; Gürdal, H; Onder, FO; Tan, A; Terzioğlu, B; Uzunalimoğlu, O; Yurdaydin, C, 2005)
"This syndrome is usually caused by endogenous dopamine deficiency but in these patients was associated with elevated dopamine metabolites in CSF and an unusual eye movement disorder: ocular flutter together with saccade initiation failure."1.32Infantile Parkinsonism-dystonia and elevated dopamine metabolites in CSF. ( Assmann, BE; Bräutigam, C; Heales, SJ; Hoffmann, GF; Hyland, K; Robinson, RO; Sharma, R; Surtees, RA; Wevers, RA; Zschocke, J, 2004)
"The Rett syndrome is a progressive disorder in female patients that is characterized by autistic behavior, dementia, ataxia, loss of purposeful use of the hands, and seizures."1.27Reduction of biogenic amine levels in the Rett syndrome. ( Butler, IJ; Glaze, DG; Percy, AK; Riccardi, VM; Zoghbi, HY, 1985)
"When reserpine was discontinued, symptoms recurred."1.26Sydenham's chorea: a possible presynaptic dopaminergic dysfunction initially. ( Naidu, S; Narasimhachari, N, 1980)
"In two patients with postanoxic action myoclonus, L-tryptophan or a monoamine oxidase inhibitor induced a moderate improvement, but L-5-hydroxytryptophan had greater therapeutic effect."1.26Beneficial effects of serotonin precursors in postanoxic action myoclonus. ( De Léan, J; Hornykiewicz, O; Richardson, JC, 1976)

Research

Studies (42)

TimeframeStudies, this research(%)All Research%
pre-199028 (66.67)18.7374
1990's9 (21.43)18.2507
2000's5 (11.90)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Assmann, BE1
Robinson, RO1
Surtees, RA1
Bräutigam, C1
Heales, SJ1
Wevers, RA1
Zschocke, J1
Hyland, K1
Sharma, R1
Hoffmann, GF1
Celik, T1
Gören, MZ1
Cinar, K1
Gürdal, H1
Onder, FO1
Tan, A1
Terzioğlu, B1
Bozdayi, AM1
Bozkaya, H1
Uzunalimoğlu, O1
Yurdaydin, C1
Squires, LN1
Talbot, KN1
Rubakhin, SS1
Sweedler, JV1
Naidu, S1
Narasimhachari, N1
Yamamoto, M1
Otsuki, S1
Miyake, K1
Namba, R1
Cramer, H1
Warter, JM1
Renaud, B1
Willemse, J1
van Nieuwenhuizen, O1
Gooskens, RH1
Westenberg, HG1
Koerber, RK1
Torkelson, R1
Haven, G1
Donaldson, J1
Cohen, SM1
Case, M1
van Kempen, GM1
Farmer, KL1
Pranzatelli, MR1
Huang, Y1
Tate, E1
Stanley, M1
Noetzel, MJ1
Gospe, SM1
Banasiak, K1
Lima, L1
Urbina, M1
Drujan, B1
Dingemanse, J1
Wallnöfer, A1
Gieschke, R1
Guentert, T1
Amrein, R1
Pasieka, JL1
McKinnon, JG1
Kinnear, S1
Yelle, CA1
Numerow, L1
Paterson, A1
Rorstad, O1
DiFrancesco, LM1
McEwan, A1
Skogseid, B1
Ramaekers, VT1
Senderek, J1
Häusler, M1
Häring, M1
Abeling, N1
Zerres, K1
Bergmann, C1
Heimann, G1
Blau, N1
Guilleminault, C2
Phillips, R1
Dement, WC2
Billiard, M1
Livrea, P1
Puca, FM1
Barnaba, A1
Di Reda, L1
Sulman, FG1
Levy, D1
Lunkan, L1
Pfeifer, Y1
Tal, E1
Lupandin, VM1
Lando, LI1
Gromova, EA1
Kamenskaia, VM1
Zykov, MB1
Diukova, GM1
Bol'shakova, TD1
Rodshtat, IV1
Dibobes, GK1
Tiabenkova, VF1
Koskiniemi, M1
Allen, N1
Knopp, W1
Michel, D1
Tommasi, M1
Laurent, B1
Trillet, M1
Schott, B1
Rüther, E2
Schilkrut, R2
Ackenheil, M2
Eben, E2
Hippius, H2
De Léan, J1
Richardson, JC1
Hornykiewicz, O1
Russell, IJ1
Vaeroy, H1
Javors, M1
Nyberg, F1
De Simoni, MG1
De Luigi, A1
Clavenna, A1
Manfridi, A1
Linnoila, VM1
Virkkunen, M1
Nagata, R1
Izumi, K1
Iwata, S1
Shimizu, T1
Fukuda, T1
Zoghbi, HY1
Percy, AK2
Glaze, DG1
Butler, IJ1
Riccardi, VM2
Zoghbi, H1
Giannini, AJ1
Malone, DA1
Piotrowski, TA1
von Knorring, L2
Oreland, L2
Häggendal, J2
Magnusson, T1
Almay, B1
Johansson, F2
Almay, BG1
Wetterberg, L1
Burns, RS1
LeWitt, PA1
Ebert, MH1
Pakkenberg, H1
Kopin, IJ1
Garelis, E1
Sourkes, TL1
Curzon, G1
Ricci, C1
Patrassi, N1
Massa, R1
Mineo, C1
Benedetti-Valentini F, J1
Riederer, P1
Birkmayer, W1
Neumayer, E1
Ambrozi, L1
Linauer, W1
Bowers, MB1

Reviews

5 reviews available for hydroxyindoleacetic acid and Syndrome

ArticleYear
[Serotonin in neurology and psychiatry].
    Nederlands tijdschrift voor geneeskunde, 1995, Oct-14, Volume: 139, Issue:41

    Topics: Brain; Brain Chemistry; Humans; Hydroxyindoleacetic Acid; Mental Disorders; Monoamine Oxidase; Recep

1995
Additional tests of interest to the dermatologist.
    Dermatologic clinics, 1994, Volume: 12, Issue:1

    Topics: alpha 1-Antitrypsin Deficiency; Angioedema; Complement C1 Inactivator Proteins; Erythema; Glucagon;

1994
Carcinoid syndrome symposium on treatment modalities for gastrointestinal carcinoid tumours: symposium summary.
    Canadian journal of surgery. Journal canadien de chirurgie, 2001, Volume: 44, Issue:1

    Topics: Algorithms; Appendiceal Neoplasms; Carcinoid Tumor; Gastrointestinal Neoplasms; Humans; Hydroxyindol

2001
Aggression, suicidality, and serotonin.
    The Journal of clinical psychiatry, 1992, Volume: 53 Suppl

    Topics: Age Factors; Aggression; Alcoholism; Circadian Rhythm; Depressive Disorder; Humans; Hydroxyindoleace

1992
The serotonin irritation syndrome--a new clinical entity?
    The Journal of clinical psychiatry, 1986, Volume: 47, Issue:1

    Topics: Animals; Anions; Anxiety; Atmosphere; Cations; Electricity; Guinea Pigs; Humans; Hydroxyindoleacetic

1986

Trials

3 trials available for hydroxyindoleacetic acid and Syndrome

ArticleYear
Cerebrospinal fluid 5-hydroxyindoleacetic acid and homovanillic acid in the pediatric opsoclonus-myoclonus syndrome.
    Annals of neurology, 1995, Volume: 37, Issue:2

    Topics: Adrenal Cortex Hormones; Child; Child, Preschool; Chromatography, High Pressure Liquid; Electrochemi

1995
Pharmacokinetic and pharmacodynamic interactions between fluoxetine and moclobemide in the investigation of development of the "serotonin syndrome".
    Clinical pharmacology and therapeutics, 1998, Volume: 63, Issue:4

    Topics: 3,4-Dihydroxyphenylacetic Acid; Adult; Antidepressive Agents; Benzamides; Blood Platelets; Drug Admi

1998
A novel neurodevelopmental syndrome responsive to 5-hydroxytryptophan and carbidopa.
    Molecular genetics and metabolism, 2001, Volume: 73, Issue:2

    Topics: 5-Hydroxytryptophan; Abnormalities, Multiple; Carbidopa; Child; Child, Preschool; Developmental Disa

2001

Other Studies

34 other studies available for hydroxyindoleacetic acid and Syndrome

ArticleYear
Infantile Parkinsonism-dystonia and elevated dopamine metabolites in CSF.
    Neurology, 2004, May-25, Volume: 62, Issue:10

    Topics: Dopamine; Dystonic Disorders; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Infant, N

2004
Fatigue of cholestasis and the serotoninergic neurotransmitter system in the rat.
    Hepatology (Baltimore, Md.), 2005, Volume: 41, Issue:4

    Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Behavior, Animal; Brain; Cholestasis; Dose-Response

2005
Serotonin catabolism in the central and enteric nervous systems of rats upon induction of serotonin syndrome.
    Journal of neurochemistry, 2007, Volume: 103, Issue:1

    Topics: 5-Hydroxytryptophan; Animals; Behavior, Animal; Brain; Central Nervous System; Disease Models, Anima

2007
Sydenham's chorea: a possible presynaptic dopaminergic dysfunction initially.
    Annals of neurology, 1980, Volume: 8, Issue:4

    Topics: Child; Chorea; Corpus Striatum; Dopamine; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Aci

1980
[Lumbar cerebrospinal fluid levels of GABA, HVA and 5HIAA in various patients with choreic movement and effects with isoniazid treatment].
    No to shinkei = Brain and nerve, 1983, Volume: 35, Issue:5

    Topics: Acanthocytes; Adult; Aged; Atrophy; Brain Diseases; Chorea; gamma-Aminobutyric Acid; Homovanillic Ac

1983
Analysis of neurotransmitter metabolites and adenosine 3',5'-monophosphate in the CSF of patients with extrapyramidal motor disorders.
    Advances in neurology, 1984, Volume: 40

    Topics: Adult; Basal Ganglia Diseases; Cyclic AMP; Female; Homovanillic Acid; Humans; Huntington Disease; Hy

1984
Treatment of non-fluctuating progressive dystonia: a neuropharmacological approach.
    Neuropediatrics, 1984, Volume: 15, Issue:4

    Topics: Adolescent; Basal Ganglia; Child; Chromatography, High Pressure Liquid; Dystonia; Female; Homovanill

1984
Increased cerebrospinal fluid 5-hydroxytryptamine and 5-hydroxyindoleacetic acid in Kleine-Levin syndrome.
    Neurology, 1984, Volume: 34, Issue:12

    Topics: Adolescent; Disorders of Excessive Somnolence; Feeding and Eating Disorders; Humans; Hydroxyindoleac

1984
Increase of the serotonin metabolite, 5-hydroxyindoleacetic acid, in cerebro-spinal fluid and spinal cord of bovines affected with the paraplegic syndrome.
    Acta cientifica venezolana, 1995, Volume: 46, Issue:3

    Topics: Animals; Cattle; Cattle Diseases; Female; Homovanillic Acid; Hydroxyindoleacetic Acid; Methoxyhydrox

1995
A syndrome of hypersomnia with automatic behavior.
    Electroencephalography and clinical neurophysiology, 1975, Volume: 38, Issue:4

    Topics: Adult; Attention; Automatism; Circadian Rhythm; Electroencephalography; Homovanillic Acid; Humans; H

1975
A menstruation-linked periodic hypersomnia. Kleine-Levin syndrome or new clinical entity?
    Neurology, 1975, Volume: 25, Issue:5

    Topics: Adolescent; Disorders of Excessive Somnolence; Electroencephalography; Estrogens, Conjugated (USP);

1975
Abnormal central monoamine metabolism in humans with "true hypersomnia" and "sub-wakefulness".
    European neurology, 1977, Volume: 15, Issue:2

    Topics: 3-Methoxy-4-hydroxyphenylethanol; Adolescent; Catechols; Child; Disorders of Excessive Somnolence; D

1977
Absence of harmful effects of protracted negative air ionisation.
    International journal of biometeorology, 1978, Volume: 22, Issue:1

    Topics: Air Ionization; Female; Histamine; Humans; Hydroxyindoleacetic Acid; Male; Serotonin; Syndrome; Thyr

1978
[Role of biogenic amines in the pathogenesis of intellectual disorders in children with minimal psychoorganic syndromes].
    Zhurnal nevropatologii i psikhiatrii imeni S.S. Korsakova (Moscow, Russia : 1952), 1978, Volume: 78, Issue:10

    Topics: Attention Deficit Disorder with Hyperactivity; Catecholamines; Child; Dihydroxyphenylalanine; Electr

1978
[Clinico-neurohumoral interrelationships in neuroses].
    Zhurnal nevropatologii i psikhiatrii imeni S.S. Korsakova (Moscow, Russia : 1952), 1978, Volume: 78, Issue:2

    Topics: 17-Hydroxycorticosteroids; Adrenal Cortex; Adult; Catecholamines; Chromaffin System; Female; Humans;

1978
Findings in routine laboratory examination in progressive myoclonus epilepsy.
    Acta neurologica Scandinavica, 1975, Volume: 51, Issue:1

    Topics: Adolescent; Adult; Age Factors; Blood Glucose; Blood Proteins; Cerebrospinal Fluid Proteins; Child;

1975
Hereditary Parkinsonism-dystonia with sustained control by L-DOPA and anticholinergic medication.
    Advances in neurology, 1976, Volume: 14

    Topics: Adolescent; Adult; Aged; Dopamine beta-Hydroxylase; Dystonia Musculorum Deformans; Female; Growth Ho

1976
[Striato-nigral degeneration. A propos of 2 anatomo-clinical cases].
    Revue neurologique, 1976, Volume: 132, Issue:1

    Topics: Brain Diseases; Corpus Striatum; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male;

1976
Clinical and biochemical parameters during neuroleptic treatment. I. Investigations with haloperidol.
    Pharmakopsychiatrie, Neuro-Psychopharmakologie, 1976, Volume: 9, Issue:1

    Topics: Adult; Female; Hallucinations; Haloperidol; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Mal

1976
Clinical and biochemical parameters during neuroleptic treatment. II. Antipsychotic effect of haloperidol in patients with chronic organic brain damage.
    Pharmakopsychiatrie, Neuro-Psychopharmakologie, 1976, Volume: 9, Issue:1

    Topics: Adult; Aged; Brain Damage, Chronic; Depression; Female; Hallucinations; Haloperidol; Homovanillic Ac

1976
Beneficial effects of serotonin precursors in postanoxic action myoclonus.
    Neurology, 1976, Volume: 26, Issue:9

    Topics: 5-Hydroxytryptophan; Aged; Carbidopa; Female; Humans; Hydroxyindoleacetic Acid; Hypoxia; Levodopa; M

1976
Cerebrospinal fluid biogenic amine metabolites in fibromyalgia/fibrositis syndrome and rheumatoid arthritis.
    Arthritis and rheumatism, 1992, Volume: 35, Issue:5

    Topics: Adult; Aged; Arthritis, Rheumatoid; Biogenic Amines; Female; Fibromyalgia; Humans; Hydroxyindoleacet

1992
In vivo studies on the enhancement of serotonin reuptake by tianeptine.
    Brain research, 1992, Mar-06, Volume: 574, Issue:1-2

    Topics: 1-Naphthylamine; Animals; Antidepressive Agents, Tricyclic; Buspirone; Drug Interactions; Hydroxyind

1992
Mechanisms of veratramine-induced 5-HT syndrome in mice.
    Japanese journal of pharmacology, 1991, Volume: 55, Issue:1

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Brain; Dopamine; Homovanillic Acid; Hydroxyindoleacetic Aci

1991
Reduction of biogenic amine levels in the Rett syndrome.
    The New England journal of medicine, 1985, Oct-10, Volume: 313, Issue:15

    Topics: Adolescent; Ataxia; Autistic Disorder; Biogenic Amines; Child; Child, Preschool; Dementia; Electroen

1985
Rett syndrome: initial experience with an emerging clinical entity.
    Brain & development, 1985, Volume: 7, Issue:3

    Topics: Adolescent; Biopsy; Child; Child Development; Child, Preschool; Electroencephalography; Female; Homo

1985
Relationship between platelet MAO activity and concentrations of 5-HIAA and HVA in cerebrospinal fluid in chronic pain patients.
    Journal of neural transmission, 1986, Volume: 66, Issue:1

    Topics: Age Factors; Blood Platelets; Body Height; Chronic Disease; Female; Homovanillic Acid; Humans; Hydro

1986
Discrimination of idiopathic pain syndromes from neurogenic pain syndromes and healthy volunteers by means of clinical rating, personality traits, monoamine metabolites in CSF, serum cortisol, platelet MAO and urinary melatonin.
    European archives of psychiatry and neurological sciences, 1986, Volume: 236, Issue:3

    Topics: Adult; Chronic Disease; Depressive Disorder; Female; Homovanillic Acid; Humans; Hydrocortisone; Hydr

1986
The clinical syndrome of striatal dopamine deficiency. Parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
    The New England journal of medicine, 1985, May-30, Volume: 312, Issue:22

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Adult; Corpus Striatum; Dopamine; Female; Homovanillic

1985
Use of cerebrospinal fluid drawn at pneumoencephalography in the study of monoamine metabolism in man.
    Journal of neurology, neurosurgery, and psychiatry, 1974, Volume: 37, Issue:6

    Topics: Adolescent; Adult; Brain Diseases; Epilepsy, Temporal Lobe; Epilepsy, Tonic-Clonic; Female; Homovani

1974
Involuntary movements other than Parkinsonism: biochemical aspects.
    Proceedings of the Royal Society of Medicine, 1973, Volume: 66, Issue:9

    Topics: Acute Disease; Animals; Athetosis; Basal Ganglia; Brain; Dopamine; Fecal Incontinence; Homovanillic

1973
Carcinoid syndrome in bronchial adenoma.
    American journal of surgery, 1973, Volume: 126, Issue:5

    Topics: Adenoma; Adult; Aged; Bronchial Neoplasms; Carcinoid Tumor; Female; Humans; Hydroxycorticosteroids;

1973
The daily rhythm of HVA, VMA, (VA) and 5-HIAA in depression-syndrome.
    Journal of neural transmission, 1974, Volume: 35, Issue:1

    Topics: Benzoates; Chromatography, Thin Layer; Circadian Rhythm; Depression; Homovanillic Acid; Humans; Hydr

1974
Central dopamine turnover in schizophrenic syndromes.
    Archives of general psychiatry, 1974, Volume: 31, Issue:1

    Topics: Affective Symptoms; Chlorpromazine; Dopamine; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic

1974